Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dupixent
Marketing
J&J's Tremfya closes out 2025 as December's top TV ad spender
All together, the top 10 spenders shelled out $285.8 million to air their TV drug ads throughout December.
Andrea Park
Jan 6, 2026 11:58am
Regeneron, AZ regulatory plans bolstered by phase 3 wins
Nov 7, 2025 2:00pm
Sanofi's Dupixent reaches quarterly sales of €4B for first time
Oct 24, 2025 11:24am
FDA approves 2nd indication for Amgen, AstraZeneca's Tezspire
Oct 17, 2025 5:12pm
AZ's Fasenra flunks COPD trial as Saphnelo makes grade in lupus
Sep 17, 2025 11:47am
Issues at Novo Nordisk’s Indiana site trip up Regeneron again
Aug 1, 2025 11:51am
